{"id":"W3083502363","doi":"10.1038/s41408-020-00357-4","title":"Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study","year":2020,"lang":"en","type":"article","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Dalhousie University","funders":"AbbVie Biotherapeutics; Bristol-Myers Squibb","keywords":"Lenalidomide; Medicine; Dexamethasone; Internal medicine; Multiple myeloma; Regimen; Hazard ratio; Clinical endpoint; Oncology; Adverse effect; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001453645,0.0002519347,0.0008650795,0.00007878869,0.0001780157,0.0001303762,0.0001860455,0.00006084463,0.0003722535],"category_scores_gemma":[0.001419674,0.0001487032,0.0001696881,0.0002141652,0.0001252944,0.0001160342,0.00008979256,0.000811171,0.00001005785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001030146,"about_ca_system_score_gemma":0.0004695335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004713737,"about_ca_topic_score_gemma":0.0006499786,"domain_scores_codex":[0.996747,0.0009383159,0.0007028774,0.0004007705,0.000760844,0.0004501704],"domain_scores_gemma":[0.9977677,0.001117358,0.000231736,0.0002333127,0.0001175934,0.0005322321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8065581,0.003736213,0.1342194,0.00003015385,0.004291557,0.005704218,0.008488241,0.00003014292,0.001444546,0.0000270666,0.001706981,0.03376332],"study_design_scores_gemma":[0.9235181,0.001270096,0.07107956,0.0001851091,0.0008425472,0.0001350188,0.001102511,0.0005380003,0.0004355516,0.0001098615,0.0006153675,0.0001682316],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839635,0.005628549,0.00003911597,0.008340861,0.0001462487,0.001341982,0.0001304395,0.00001922063,0.0003900517],"genre_scores_gemma":[0.995623,0.002309217,0.0003323585,0.0006456617,0.0007826367,0.00009530854,0.0000234752,0.0000270303,0.0001613138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.11696,"threshold_uncertainty_score":0.7125791,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1002394415893604,"score_gpt":0.3762224000222738,"score_spread":0.2759829584329133,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}